Hepatocyte transplantation in children with liver cell failure
Keywords:
Hepatocyte transplantation, Liver cell failure, Metabolic liver diseaseAbstract
Patients with hepatic failure and liver-based metabolic disorders require management which is both costly and complex. Hepatocyte transplantation has been very encouraging as an alternative to organ transplantation for liver disease treatment, and studies in rodents, show that transplants involving isolated liver cells can reverse hepatic failure, and correct various metabolic deficiencies of the liver. This 2016 review is based on a literature search using PubMed including original articles, reviews, cases and clinical guidelines. The search terms were "hepatocyte transplantation", "liver transplantation", "liver cell failure", "metabolic liver disorders", "orthotropic liver transplantation", "hepatocytes" and "stem cell transplantation". The goal of this review is to summarize the significance of hepatocyte transplantation, the sources of hepatocytes and the barriers of hepatocyte transplantation using a detailed review of literature. Our review shows that treatment of patients with liver disease by hepatocyte transplantation has expanded exponentially, especially for patients suffering from liver-based metabolic disorders. Once hepatocyte transplantation has been shown to effectively replace organ transplantation for a portion of patients with life-threatening liver metabolic diseases and those with liver failure it will make cell therapy effective and available for a broad population of patients with liver disorders.
References
Khan AA, Parveen N, Habeeb MA, Paspala S, Rajendraprasad A, Mahaboob Vali S, et al. Cell Therapy for
Acute Liver Failure - Ideal source of cell. J Stem Cells Regen Med. 2008; 4(1): 2-8. PMID: 24693024,
PMCID: PMC3908132.
Khan AA, Parveen N, Habeeb MA, Habibullah CM. Journey from hepatocyte transplantation to hepatic
stem cells: a novel treatment strategy for liver diseases. Indian J Med Res. 2006; 123(5): 601-14. PMID:
Stieger B, Peters R, Sidler MA, Meier PJ. Hepatocyte transplantation: potential of hepatocyte progenitor
cells and bone marrow derived stem cells. Swiss med wkly. 2006; 136: 552-6. PMID: 17043946.
Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech
Dev. 2003; 120(1): 117-30. doi: 10.1016/S0925-4773(02)00338-6. PMID: 12490302.
Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. The origin and liver repopulating
capacity of murine oval cells. Proc Natl Acad Sci U S A. 2003; 100(1): 11881-8. doi:
1073/pnas.1734199100. PMID: 12902545, PMCID: PMC304102.
Laurson J, Selden C, Hodgson HJ. Hepatocyte progenitors in man and in rodents–multiple pathways,
multiple candidates. Int J Exp Pathol. 2005; 86(1): 1-18. doi: 10.1111/j.0959-9673.2005.00410.x. PMID:
, PMCID: PMC2517398.
Lazaro CA, Rhim JA, Yamada Y, Fausto N. Generation of hepatocytes from oval cell precursors in culture.
Cancer Res. 1998; 58: 5514-22. PMID: 9850088.
Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a
potential source of hepatic oval cells. Science. 1999; 284(5417): 1168-70. doi:
1126/science.284.5417.1168. PMID: 10325227.
Theise ND, Badve S, Saxena R, Henegariu O, Sell S, Crawford JM, et al. Derivation of hepatocytes from
bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000; 31(1): 235-40. doi:
1002/hep.510310135. PMID: 10613752.
Alison MR, Poulsom R, Jeffery R, Dhillon AP, Quaglia A, Jacob J, et al. Hepatocytes from non-hepatic
adult stem cells. Nature. 2000; 406(6793): 257. doi: 10.1038/35018642. PMID: 10917519.
Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion.
Nature. 2003; 422(6934): 901-4. doi: 10.1038/nature01539. PMID: 12665833.
Aejaz HM, Khan AA, Parveen N, Baskar S, Mahaboob V, Khaja MN, et al. Stem Cells in Hepatobiliary
Diseases. J Stem Cells Regen Med. 2006; 1(1): 2-7. PMID: 24692856, PMCID: PMC3907966.
Sorino HE, Wood RP, Kang DC. Hepatocellular transplantation (HCT) in children with fulminant hepatic
failure. Hepatology. 1997; 26: 239.
Khan AA, Habeeb A, Parveen N, Naseem B , Babu RP , Capoor AK, et al. Peritoneal transplantation of
human fetal hepatocytes for the treatment of acute fatty liver pregnancy. a case report. Trop Gastroenterol.
; 25(3): 141-3. PMID: 15682663.
Fox IJ, Roy Chowdhary J, Kauffman SS, Goertzen TC, Chowdhury NR, Warkentin PI, et al. Treatment of
the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998; 338(20): 1422-6.
doi: 10.1056/NEJM199805143382004. PMID: 9580649.
Sokal EM, Smets F, Bourgos A, Van Maldergem L, Buts JP, Reding R, et al. Hepatocyte transplantation in
a 4-year girl with peroxisomal biogenesis disease: technique, safety and metabolic follow-up.
Transplantation. 2003; 76(4): 735-8. doi: 10.1097/01.TP.0000077420.81365.53. PMID: 12973120.
Horslen SP, Fox IJ. Hepatocyte transplantation. Transplantation. 2004; 77(10): 1481-6. doi:
1097/01.TP.0000113809.53415.C2. PMID: 15239608.
Hewitt NJ, Lechón MJG, Houston JB, Hallifax D, Brown HS, Maurel P, et al. Primary hepatocyte: Current
understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice
for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity
studies. Drug Metabolism Reviews. 2007; 39(1): 159-234. doi: 10.1080/03602530601093489. PMID:
Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S, et al. Hepatocyte transplantation for
inherited factor VII deficiency. Transplantation. 2004; 78(12): 1812–4. doi:
1097/01.TP.0000146386.77076.47. PMID: 5614156.
Newsome PN, Plevris JN, Nelson LJ, Hayes PC. Animal models of fulminant hepatic failure: a critical
evaluation. Liver Transpl. 2000; 6(1): 21–31. doi: 10.1002/lt.500060110. PMID: 10648574.
Sudan DL, Shaw Jr BW, Fox IJ, Langnas AN. Long-term follow-up of auxiliary orthotopic liver
transplantation for the treatment of fulminant hepatic failure. Surgery. 1997; 122(4): 778–8, 777–8. doi:
1016/S0039-6060(97)90086-6. PMID: 9347855.
Rozga J. Liver support technology-an update. Xenotransplantation. 2006; 13(1): 380–9. doi:
1111/j.1399-3089.2006.00323.x. PMID: 16925661.
Lee WM, Squires Jr RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop.
Hepatology. 2008; 47(4): 1401-15. doi: 10.1002/hep.22177. PMID: 18318440, PMCID: PMC3381946.
Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc. 1992; 24(6): 3052-3.
PMID: 1466053.
Nagata H, Ito M, Cai J, Edge AS, Platt JL, Fox IJ. Treatment of cirrhosis and liver failure in rats by
hepatocyte xenotransplantation. Gastroenterology. 2003; 124(2): 422-31. doi: 10.1053/gast.2003.50065.
PMID: 12557148.
Nagata H, Ito M, Shirota C, Edge A, McCowan TC, Fox IJ. Route of hepatocyte delivery affects hepatocyte
engraftment in the spleen. Transplantation. 2003; 76(4): 732-4. doi: 10.1097/01.TP.0000081560.16039.67.
PMID: 12973119.
Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, et al. Perfusion decellularized matrix:
using nature’s platform to engineer a bioartificial heart. Nat Med. 2008; 14(2): 213-21. doi:
1038/nm1684. PMID: 18193059.
Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, et al. Organ re-engineering:
development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med. 2010;
: 814–20. doi: 10.1038/nm.2170. PMID: 20543851, PMCID: PMC2930603.
Nagata H, Nishitai R, Shirota C, Zhang JL, Koch CA, Cai J, et al. Prolonged survival of porcine
hepatocytes in cynomolgus monkeys. Gastroenterology. 2007; 132(1): 321-9. doi:
1053/j.gastro.2006.10.013. PMID: 17241882.
Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M, et al. Serial transplantation reveals the stem- cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol. 1997; 151(1): 1273-80. PMID:
, PMCID: PMC1858091.
Guo D, Fu T, Nelson JA, Superina RA, Soriano HE. Liver repopulation after cell transplantation in mice
treated with retrorsine and carbon tetrachloride. Transplantation. 2002; 73(11): 1818-24. doi:
1097/00007890-200206150-00020. PMID: 12085007.
Peters LJ, Withers HR, Cundiff JH, Dicke KA. Radiobiological considerations in the use of total-body
irradiation for bone-marrow transplantation. Radiology. 1979; 131(1): 243-7. doi: 10.1148/131.1.243.
PMID: 370902.
Guha C, Sharma A, Gupta S, Alfieri A, Gorla GR, Gagandeep S, et al. Amelioration of radiation-induced
liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res. 1999; 59(23):
–4. PMID: 10606225.
Dagher I, Nguyen TH, Groyer-Picard MT, Lainas P, Mainot S, Guettier C, et al. Efficient hepatocyte
engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates.
Hepatology. 2009; 49(3): 950-9. doi: 10.1002/hep.22739. PMID: 19152424.
Fox IJ, Roy-Chowdhury J. Hepatocyte transplantation. J Hepatol. 2004; 40: 878-86. doi:
1016/j.jhep.2004.04.009. PMID: 15158325.
Yamanouchi K, Zhou H, Roy-Chowdhury N, Macaluso F, Liu L, Yamamoto T, et al. Hepatic irradiation
augments engraftment of donor cells following hepatocyte transplantation. Hepatology. 2009; 49(1): 258- 67. doi: 10.1002/hep.22573. PMID: 19003915, PMCID: PMC3416044.
Guha C, Yamanouchi K, Jiang J, Wang X, Roy Chowdhury N, Santana A, et al. Feasibility of hepatocyte
transplantation-based therapies for primary hyperoxalurias. Am J Nephrol. 2005; 25(2): 161-70. doi:
1159/000085408. PMID: 15849463.
Mitry RR, Dhawan A, Hughes RD, Bansal S, Lehec S, Terry C, et al. One liver, three recipients: segment
IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation. 2004;
(10): 1614-6. doi: 10.1097/01.TP.0000122224.98318.19. PMID: 15239631.
Hughes RD, Mitry RR, Dhawan A, Lehec SC, Girlanda R, Rela M, et al. Isolation of hepatocytes from
livers from non-heart-beating donors for cell transplantation. Liver Transpl. 2006; 12(5): 713-7. doi:
1002/lt.20732. PMID: 16528714.
Meyburg J, Das AM, Hoerster F, Lindner M, Kriegbaum H, Engelmann G, et al. One liver for four
children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects.
Transplantation. 2009; 87(5): 636-41. doi: 10.1097/TP.0b013e318199936a. PMID: 19295306.
Puppi J, Dhawan A. Human hepatocyte transplantation overview. Methods Mol Biol. 2009; 481: 1-16. doi:
1007/978-1-59745-201-4-1. PMID: 19096807.
Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, et al. Highly efficient generation of human
hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2010; 51(1): 297-305. doi:
1002/hep.23354. PMID: 19998274, PMCID: PMC2946078.
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, et al. Human induced pluripotent stem cells free
of vector and transgene sequences. Science. 2009; 324(5968): 797-801. doi: 10.1126/science.1172482.
PMID: 19325077, PMCID: PMC2758053.
Platt JL. New directions for organ transplantation. Nature. 1998; 392(6679): 11-7. doi: 10.1038/32023.
PMID: 9579856.
Gunsalus JR, Brady DA, Coulter SM, Gray BM, Edge AS. Reduction of serum cholesterol in Watanabe
rabbits by xenogeneic hepatocellular transplantation. Nat Med. 1997; 3(1): 48-53. doi: 10.1038/nm0197-48.
PMID: 8986740.
Yamada K, Yazawa K, Shimizu A, Iwanaga T, Hisashi Y, Nuhn M, et al. Marked prolongation of porcine
renal xenograft survival in baboons through the use of alpha1, 3-galactosyltransferase gene-knockout
donors and the cotransplantation of vascularized thymic tissue. Nat Med. 2005; 11(1): 32-4. doi:
1038/nm1172. PMID: 15619627.
Walker CM. Comparative features of hepatitis C virus infection in humans and chimpanzees. Springer
Semin Immunopathol. 1997; 19(1): 85-98. doi: 10.1007/BF00945027. PMID: 9266633.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
